Sentences with phrase «with head and neck cancer»

Among the Center's affiliations have been those with North General Hospital, serving low income families with diabetes, asthma, chronic pain, cancer and HIV / AIDS; The Family Center, working with families coping with the loss of a parent to cancer or HIV / AIDS; Maimonides Hospital, dealing with couples in which one spouse has cardiac illness; Memorial Sloan - Kettering Cancer Center, offering services to families with head and neck cancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diabetes.

In a separate analysis, the investigators compared over 1,050 smokers with head and neck cancer with nearly 800 smokers without the disease.

Research suggests that zinc supplementation does not improve survival rates after 3 years in people with head and neck cancer.

Also utilizing imaging, PIs Joseph Paydarfar, MD, Ryan Halter, PhD, and David Pastel, MD, will test their solution to the problem that, in patients with head and neck cancer, significant tissue deformation occurs during laryngoscopy, rendering pre-operative images unusable for assessing tumor extent and location of critical structures.

As a surgeon who treats patients with head and neck cancer, Kim approaches research from a translational standpoint to understand the relationship between neoplastic transformation and the host immune response.

The five - year survival rate of patients with head and neck cancer is about 60 %.

Several trials of adoptive T cell transfer techniques are currently under way for patients with head and neck cancer, including:

A systematic review of observational studies suggested that smoking cessation after bladder cancer is beneficial, but owing to confounding and methodological concerns of included studies no firm conclusions could be drawn.30 Some observational studies have also shown an association between smoking cessation in patients with head and neck cancer and reduced risk of disease progression and mortality, but the absence of a systematic review and meta - analysis means that the strength of this association is uncertain.31 32 33

Radiation therapy is a lifesaver for patients with head and neck cancer, but the treatment takes a toll on the salivary gland.

If you've been diagnosed with a head and neck cancer, talk to us about treatment options.

If you have been diagnosed with a head and neck cancer, are at a high risk for developing this disease or are looking for a second opinion consultation about your treatment, you may request an appointment online or contact us at 800-826-4673 (HOPE).

Patients with head and neck cancer seldom survive for longer than six months to one year when treated with chemotherapy alone.

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Comprehensive Cancer Center.

«With head and neck cancer, we often clear patients of cancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excellence.

To investigate why checkpoint inhibitors so often stop working, Velculescu; Valsamo Anagnostou, M.D., Ph.D., instructor of oncology at the Johns Hopkins University School of Medicine; Kellie N. Smith, Ph.D., a cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-CTLA4.

Dr. Islam saw this phenomenon occur in cell culture and in some samples from patients with head and neck cancers.

Having only people with head and neck cancers in the study eliminates the variability of a group suffering from different forms of the disease, but it also eliminates information about whether patients with other forms of cancer would show the same results.

Between 28 % and 67 % of people diagnosed with head and neck cancers in England survive their disease for five years or more (2009 - 13).

Between 32 % to 75 % of patients diagnosed with head and neck cancers cancer have surgery to remove the tumour as part of their primary cancer treatment.

Between 61 % and 86 % of people diagnosed with head and neck cancers in England survive their disease for one year or more (2009 - 13).

Between 8 % and 61 % of patients diagnosed with head and neck cancers have chemotherapy as part of their primary cancer treatment.

Medical oncologist Alexander T. Pearson, MD, PhD cares for adults with head and neck cancers, especially squamous cell carcinoma, a common form of cancer that develops in the squamous cells that make up the middle and outer layer lining the mouth and throat.

Dr. Eduardo Méndez has received a five - year, $ 2.2 million grant from the National Institutes of Health to develop the first targeted therapy that they hope will be effective for most patients with head and neck cancers.

An estimated 55,000 patients are diagnosed each year with head and neck cancers, which includes cancers of the mouth and throat.

Not exact matches

Cancer - free following his latest quarterly checkup, ex-Buffalo Bills Hall - of - Fame quarterback Jim Kelly is drawing on his experiences to aid others battling head and neck cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted Cancer - free following his latest quarterly checkup, ex-Buffalo Bills Hall - of - Fame quarterback Jim Kelly is drawing on his experiences to aid others battling head and neck cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted cancer, teaming up with several cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted cancer organizations and pharmaceutical giant Merck to produce a promotional campaign titled «Your Cancer Game Plan,» which debuted Cancer Game Plan,» which debuted today.

Epstein - Barr is best known for causing infectious mononucleosis, but it is also associated with an increased risk for several cancers, as well as a rare type of head and neck cancer called nasopharyngeal carcinoma.

She and other colleagues first noticed an odd shift in patient profiles in the late 1990s: younger men were showing up in her clinic, often with no significant history of smoking or heavy drinking, which are risk factors for head and neck cancers.

Now head and neck cancers associated with the virus are on the rise, leading some experts to recommend that a gender - neutral or male - centric approach might be more effective.

«New radiotracer helps avoid neck dissection in patients with early head and neck cancer.»

Immunotherapy doubles overall survival and improves quality of life, with fewer side effects, in a treatment - resistant and rapidly progressing form of head and neck carcinoma, reports a large, randomized international trial co-led by investigators at the University of Pittsburgh Cancer Institute (UPCI).

«These exciting results indicate that there is a new standard of care option for a population of head and neck cancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program at Uhead and neck cancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program atcancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program at UHead and Neck Surgery and co-leader of the Cancer Immunology Program atCancer Immunology Program at UPCI.

The authors report that higher levels of physical activity compared to lower levels were associated with lower risks of 13 of 26 cancers: esophageal adenocarcinoma (42 percent lower risk); liver (27 percent lower risk); lung (26 percent lower risk); kidney (23 percent lower risk); gastric cardia (22 percent lower risk); endometrial (21 percent lower risk); myeloid leukemia (20 percent lower risk); myeloma (17 percent lower risk); colon (16 percent lower risk); head and neck (15 percent lower risk), rectal (13 percent lower risk); bladder (13 percent lower risk); and breast (10 percent lower risk).

The highest prevalence was found among patients with breast cancer (42 %) and head and neck cancer (41 %), followed by malignant melanoma (39 %).

• Speech language pathologists work with many types of patients including those who have cochlear implantation surgery, suffer from a voice disorder or during rehabilitation following treatment for head and neck cancer.

Yang et al. report on one such strategy: Taking the knowledge that an increase in type I interferons (IFNs) correlates positively with clinical outcome in several cancers and that type I IFNs can enhance antitumor immunity in some models, the authors tethered IFN - β to a monoclonal antibody targeting the epithelial growth factor receptor (EGFR), which is approved for use in treating metastatic colorectal cancer and head and neck cancer.

2003 Chinese company Shenzhen SiBiono GeneTech gains approval for treating head and neck cancer with Gendicine, a modified adenovirus carrying a tumour - suppressor gene.

Long associated with liver cancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck cacancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck caCancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and neck cancers.

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

Patients with HCV - positive head and neck cancers were more likely to also test positive for HPV.

Other recent studies have recognized HCV's increased association with additional cancers, says Torres, but there was no known association with a significant number of head and neck cancers.

«People with hepatitis C are two to five times more likely to develop certain head and neck cancers: first study to find association with new cancer types; findings have strong implications for screening and treatment.»

Dr. Bauman also collaborated with senior author Daniel E. Johnson, Ph.D., professor of medicine at Pitt and a senior scientist in the UPCI Head and Neck Cancer Program, to see how the extract performed in mice predisposed to head and neck canHead and Neck Cancer Program, to see how the extract performed in mice predisposed to head and neck cCancer Program, to see how the extract performed in mice predisposed to head and neck canhead and neck cancercancer.

At enrollment, e-cigarette users were more nicotine dependent than non-users, had more prior quit attempts, and were more likely to be diagnosed with lung or head and neck cancers.

Dr. Bauman and her colleagues treated human head and neck cancer cells in the laboratory with varying doses of sulforaphane and a control, and compared them to normal, healthy cells that line the throat and mouth.

The VA - UAB team says, based on its lab studies, that honokiol binds more strongly with EGFR than does the drug gefitinib (sold as Iressa), which is commonly used to treat head and neck cancers.

«The decrease in the rate of new cancers was unexpected; however, the large database and the long follow - up provided us with a window into information that had not previously been available about the long - term patterns of head and neck tumors and is particularly heartening.

«This study, one of only a few large studies to have follow - up beyond five years, demonstrates that patients who have head and neck cancers and who are being treated with radiation therapy alone have improved local - regional control and no increase in late toxicity when radiation therapy is delivered twice a day in two smaller doses which we call hyperfractionation,» said Jonathan J. Beitler, MD, MBA, FASTRO, lead author of the study and professor of radiation oncology, otolaryngology and hematology / medical oncology at the Winship Cancer Institute of Emory University School of Medicine in Atlanta.

They discovered that people with both head and neck squamous cell carcinoma and the KRAS - variant who were treated with standard treatment, but not with cetuximab, had a higher risk of failing treatment and developing metastatic disease, meaning the cancer spreads to distant organs and is incurable.

«Given the lack of universal HPV immunization and the potential for the virus to evade the immune system even in individuals with detectable HPV in their blood, our findings could have far - reaching implications for identifying people at risk of developing HPV - related head and neck cancers and ultimately preventing them,» Miller said.

New studies from the Abramson Cancer Center of the University of Pennsylvania are providing fresh clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic cCancer Center of the University of Pennsylvania are providing fresh clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic ccancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic ccancer, and also providing greater understanding of the mechanisms of resistance in pancreatic cancercancer.